Cefpodoxime
- CAS No.
- 80210-62-4
- Chemical Name:
- Cefpodoxime
- Synonyms
- CPDX;Cefpodoxima;Cefpodoxime;Cefpodoximum;Unii-7R4F94tvgy;Cefpodoxime sulfate;Cefpodoximum [latin];Cefpodoxima [spanish];Cefpodoxime USP/EP/BP;Cefpodoxime tablet 200mg
- CBNumber:
- CB9511604
- Molecular Formula:
- C15H17N5O6S2
- Molecular Weight:
- 427.46
- MDL Number:
- MFCD00864906
- MOL File:
- 80210-62-4.mol
- MSDS File:
- SDS
| Melting point | 200-202°C |
|---|---|
| Density | 1.78±0.1 g/cm3(Predicted) |
| RTECS | XI0367365 |
| storage temp. | Sealed in dry,Store in freezer, under -20°C |
| solubility | Soluble in DMSO |
| pka | 2.77±0.50(Predicted) |
| form | Solid |
| color | White to off-white |
| Sensitive | Light Sensitive |
| BRN | 6021381 |
| Stability | Hygroscopic |
| FDA UNII | 7R4F94TVGY |
| ATC code | J01DD13 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS08 |
|---|---|
| Signal word | Danger |
| Hazard statements | H317-H334 |
| Precautionary statements | P261-P280-P342+P311 |
| Hazard Codes | Xn |
| Risk Statements | 42/43 |
| Safety Statements | 22-36/37-45 |
| WGK Germany | 3 |
Cefpodoxime price More Price(15)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | 32344 | Cefpodoxime VETRANAL | 80210-62-4 | 25mg | $81.1 | 2024-03-01 | Buy |
| Alfa Aesar | J66225 | Cefpodoxime, 98% | 80210-62-4 | 1g | $394 | 2024-03-01 | Buy |
| Cayman Chemical | 16075 | Cefpodoxime (free acid) ≥95% | 80210-62-4 | 10mg | $32 | 2024-03-01 | Buy |
| Cayman Chemical | 16075 | Cefpodoxime (free acid) ≥95% | 80210-62-4 | 25mg | $66 | 2024-03-01 | Buy |
| Cayman Chemical | 16075 | Cefpodoxime (free acid) ≥95% | 80210-62-4 | 50mg | $121 | 2024-03-01 | Buy |
Cefpodoxime Chemical Properties,Uses,Production
Chemical Properties
Off-White Solid
Uses
Cefpodoxime Proxetil metabolite antibiotic
Uses
A metabolite of Cefpodoxime Proxetil. An antibacterial.
Uses
A metabolite of Cefpodoxime Proxetil (C243860). An antibacterial.
Definition
ChEBI: A third-generation cephalosporin antibiotic with methoxymethyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamino substituents at positions 3 and 7, respectively, of the cephem skeleton. Given by mouth as its proxetil ester prodrug, it is used to treat acute otitis media, pharyngitis, and sinusitis.
brand name
Vantin (Pharmacia & Upjohn).
Antimicrobial activity
It is stable to a wide range of plasmid-mediated β-lactamases. It induces the chromosomal β-lactamases of Ps. aeruginosa, Enterobacter spp., S. marcescens and Citrobacter spp., but is a less potent inducer than cefoxitin.
Biological Activity
cefpodoxime, as known as r 3763, is a metabolite of cefpodoxime proxetil. it is demonstrated that cefpodoxime, as an oral third generation cephalosporin antibiotic, is active against most gram-positive and gram-negative bacteria.cefpodoxime suppresses bacterial septum and cell wall synthesis by binding to penicillin-binding proteins (pbps) located in the bacterial cytoplasmic membrane.
Pharmacokinetics
Oral absorption: c. 50%
Cmax 200 mg oral: 2.1 mg/L after 3 h
Plasma half-life: c. 2.2 h
Volume of distribution: c. 35 L
Plasma protein binding: 20–30%
Absorption and distribution
The ester is rapidly hydrolyzed to the parent compound in the small intestine. Bioavailability increases to 65% if taken with food, but antacids and H2-receptor antagonists reduce absorption. Unabsorbed drug is hydrolyzed and excreted in the feces.
It is well distributed and penetrates well into tissues (including lung tissue) and inflammatory exudate to achieve concentrations inhibitory to common pathogens.
Metabolism and excretion
The hydrolyzed prodrug is not subject to further metabolism. About 80% of the absorbed compound (30–40% of the original dose) appears in the urine over 24 h. Excretion is by glomerular filtration and tubular secretion; probenecid delays secretion and increases the peak plasma concentration.
Metabolism and excretion
The hydrolyzed prodrug is not subject to further metabolism. About 80% of the absorbed compound (30–40% of the original dose) appears in the urine over 24 h. Excretion is by glomerular filtration and tubular secretion; probenecid delays secretion and increases the peak plasma concentration.
Clinical Use
Cefpodoxime has been used principally for the treatment of upper and lower respiratory tract infections in children and adults.
Side effects
The drug is well tolerated, but gastrointestinal disturbance with diarrhea is common. Pseudomembranous colitis has been reported occasionally. Other side effects are those common to cephalosporins.
in vitro
cefpodoxime showed antibacterial activities against obligatory anaerobes and salmonella spp., shigella spp. and neisseria meningitides. the activity of cefpodoxime was less active than r95867, an active form of cs-834, against gram-negative bacteria [1]. cefpodoxime was quite stable to hydrolysis by β-lactamases produced from b. cereus and e. coli hb101/pbr322 [2].
in vivo
male ddy mice were administered orally in a volume of 0.2 ml of 0.5% carboxymethyl cellulose sodium salt. after 7 days, it was shown that cefpodoxime had good efficacy against streptococcus spp. and k. pneumoniae infection in mice [1].
References
[1]. sakagawa, e., otsuki, m., oh, t., & nishino, t. in-vitro and in-vivo antibacterial activities of cs-834, a new oral carbapenem. journal of antimicrobial chemotherapy, 1998; 42: 426-437.
[2]. fukuoka, t., ohya, s., utsui, y., domon, h., takenouchi, t., koga, t., … kuwahara, s. in vitro and in vivo antibacterial activities of cs-834, a novel oral carbapenem. antimicrobial agents and chemotherapy, 1997; 41(12): 2652–2663.
Cefpodoxime Preparation Products And Raw materials
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Hebei Chuanghai Biotechnology Co,.LTD | +86-13131129325 | sales1@chuanghaibio.com | China | 5892 | 58 |
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 | info@tianfuchem.com | China | 21634 | 55 |
| Standardpharm Co. Ltd. | 86-714-3992388 | overseasales1@yongstandards.com | United States | 14332 | 58 |
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19553 | 58 |
| CONIER CHEM AND PHARMA LIMITED | +8618523575427 | sales@conier.com | China | 49374 | 58 |
| career henan chemical co | +86-0371-86658258 +8613203830695 | factory@coreychem.com | China | 29811 | 58 |
| Shaanxi Dideu Medichem Co. Ltd | +86-029-89586680 +86-18192503167 | 1026@dideu.com | China | 7724 | 58 |
| AFINE CHEMICALS LIMITED | +86-0571-85134551 | sales@afinechem.com | China | 15354 | 58 |
| Dayang Chem (Hangzhou) Co.,Ltd. | 571-88938639 +8617705817739 | info@dycnchem.com | China | 52849 | 58 |
| sgtlifesciences pvt ltd | +8617013299288 | dj@sgtlifesciences.com | China | 12373 | 58 |
Related articles
- Cefpodoxime: Antimicrobial Activity, Susceptibility, Administration and Dosage, Clinical Uses etc.
- Cefpodoxime is another oral third-generation cephalosporin, which has good stability to many beta-lactamases and activity agai....
- Mar 24，2022
View Lastest Price from Cefpodoxime manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2024-10-11 | Cefpodoxime
80210-62-4
|
US $80.70 / kg | 10kg | 99% | 10000kg | Hebei Chuanghai Biotechnology Co,.LTD | |
 |
2020-05-25 | Cefpodoxime
80210-62-4
|
US $0.00-0.00 / Kg | 1KG | 99.0%+ | 300 MT | Shaanxi Dideu Medichem Co. Ltd | |
 |
2019-12-26 | Cefpodoxime
80210-62-4
|
US $1.00 / g | 1g | ≥98% | g/kg/Ton | Career Henan Chemical Co |
-
- Cefpodoxime
80210-62-4
- US $80.70 / kg
- 99%
- Hebei Chuanghai Biotechnology Co,.LTD
-
- Cefpodoxime
80210-62-4
- US $0.00-0.00 / Kg
- 99.0%+
- Shaanxi Dideu Medichem Co. Ltd
-
- Cefpodoxime
80210-62-4
- US $1.00 / g
- ≥98%
- Career Henan Chemical Co
80210-62-4(Cefpodoxime)Related Search:
1of4